#
Kura Oncology (KURA) stock forecast for 2025

Last update: September 27, 2023 (17:07)

Sector: Healthcare### The share price of Kura Oncology, Inc. (KURA) now

50/200 Day Moving Average: $10.23 / $11.61

This figure corresponds to the Average Price over the previous 50/200 days. For Kura Oncology stocks, the 50-day moving average is the resistance level today.

For Kura Oncology stocks, the 200-day moving average is the resistance level today.

Are you interested in Kura Oncology stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kura Oncology stock price in 2025. How much will one Kura Oncology share be worth in 2025? Is it worth taking profit / loss on Kura Oncology stock now or waiting? What are analysts' forecasts for Kura Oncology stock?

We forecast Kura Oncology stock performance using neural networks based on historical data on Kura Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. The Kura Oncology stock prediction results are shown below and presented as a graph, table and text information.

Kura Oncology stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Kura Oncology analysts is $29.88.

Today 200 Day Moving Average is the resistance level (11.61 $).

50 Day Moving Average is the resistance level (10.23 $).

### Historical and forecast chart of Kura Oncology stock

The chart below shows the historical price of Kura Oncology stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kura Oncology stock price can be found in the table below.

### Kura Oncology (KURA) Forecast for 2025

Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|

Jan | 8.39 | 7.91 | 9.08 | 12.96 % |

Feb | 7.89 | 7.48 | 8.13 | 7.95 % |

Mar | 7.45 | 6.78 | 8.21 | 17.35 % |

Apr | 8.03 | 7.46 | 8.38 | 10.97 % |

May | 7.03 | 6.50 | 7.59 | 14.33 % |

Jun | 7.15 | 6.57 | 7.36 | 10.62 % |

Jul | 7.08 | 6.49 | 7.61 | 14.75 % |

Aug | 7.18 | 6.58 | 7.85 | 16.17 % |

Sep | 6.82 | 6.60 | 7.18 | 8.03 % |

Oct | 7.67 | 6.97 | 8.42 | 17.29 % |

Nov | 7.38 | 6.84 | 8.08 | 15.42 % |

Dec | 7.62 | 7.06 | 7.97 | 11.44 % |

### Kura Oncology information and performance

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA, US

Market capitalization of the Kura Oncology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KURA shares in the company outstanding by the market price of one share.

EBITDA of Kura Oncology is earnings before interest, income tax and depreciation of assets.

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

Price/earnings to growth

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS shows how much of the net profit is accounted for by the common share.

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward P/E uses projections of future earnings instead of final numbers.

Enterprise Value (EV) /Revenue

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Number of issued ordinary shares

Number of freely tradable shares

Shares Short Prior Month - the number of shares in short positions in the last month.

### Kura Oncology price target for 2025 by month

#### Target values for the price of one Kura Oncology share for Jan 2025.

In Jan, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 12.962% volatility is expected.

Pessimistic target level: 7.91

Optimistic target level: 9.08

#### Target values for the price of one Kura Oncology share for Feb 2025.

In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 7.952% volatility is expected.

Pessimistic target level: 7.48

Optimistic target level: 8.13

#### Target values for the price of one Kura Oncology share for Mar 2025.

In Mar, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 17.351% volatility is expected.

Pessimistic target level: 6.78

Optimistic target level: 8.21

#### Target values for the price of one Kura Oncology share for Apr 2025.

In Apr, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.969% volatility is expected.

Pessimistic target level: 7.46

Optimistic target level: 8.38

#### Target values for the price of one Kura Oncology share for May 2025.

In May, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 14.333% volatility is expected.

Pessimistic target level: 6.50

Optimistic target level: 7.59

#### Target values for the price of one Kura Oncology share for Jun 2025.

In Jun, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.616% volatility is expected.

Pessimistic target level: 6.57

Optimistic target level: 7.36

#### Target values for the price of one Kura Oncology share for Jul 2025.

In Jul, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 14.748% volatility is expected.

Pessimistic target level: 6.49

Optimistic target level: 7.61

#### Target values for the price of one Kura Oncology share for Aug 2025.

In Aug, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 16.167% volatility is expected.

Pessimistic target level: 6.58

Optimistic target level: 7.85

#### Target values for the price of one Kura Oncology share for Sep 2025.

In Sep, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 8.032% volatility is expected.

Pessimistic target level: 6.60

Optimistic target level: 7.18

#### Target values for the price of one Kura Oncology share for Oct 2025.

In Oct, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 17.294% volatility is expected.

Pessimistic target level: 6.97

Optimistic target level: 8.42

#### Target values for the price of one Kura Oncology share for Nov 2025.

In Nov, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.417% volatility is expected.

Pessimistic target level: 6.84

Optimistic target level: 8.08

#### Target values for the price of one Kura Oncology share for Dec 2025.

In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 11.440% volatility is expected.

Pessimistic target level: 7.06

Optimistic target level: 7.97

### Related stocks from Healthcare sector

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.